\-\ Texto\\:\\ \ \(0\)\
\-\ non\\ contributory\ \(16\)\
\-\ followed\\ by\\ ct\\ over\\ a\\ 10\\ month\\ period\\ with\\ stability\\ over\\ time\\.\ \(0\)\
\-\ the\\ right\\ adrenal\\ gland\\ is\\ enlarged\\ and\\ demonstrates\\ a\ \(0\)\
\-\ heterogeneous\\ attenuation\\.\\ \\ a\\ foci\\ of\\ fat\\ attenuated\\ region\\ is\\ noted\\ within\\ this\\ adrenal\\ lesion\\.\\ \\ the\\ right\\ adrenal\\ gland\\ measures\\ 3\\.2cmx2\\.7cmx3\\.0cm\\.\ \(0\)\
\-\ adrenal\\ mass\\ \\-\\ considered\\ to\\ be\\ benign\\ lesion\\ with\\ stability\\ over\\ 10\\ months\\ of\\ imaging\\.\\ likely\\ myelolipoma\\ given\\ imaging\\ characteristics\\.\ \(0\)\
\-\ higher\\ on\\ list\\ despite\\ focal\\ fat\\:\\ metastases\ \(0\)\
\-\ other\\:\\ myelolipoma\\,\\ adenoma\\,\\ paraganglioma\\,\\ ganglioneuroma\\,\\ pseudotumor\ \(0\)\
\-\ post\\ op\\ day\\ \\#14\\ status\\ post\\ emergency\\ total\ \(0\)\
\-\ colectomy\\ for\\ large\\ bowel\\ obstruction\\ for\\ stage\\ iii\\ colon\\ cancer\\.\\ \\ the\\ patient\\ was\\ re\\-admitted\\ for\\ intractable\\ vomiting\\ and\\ elevated\\ white\\ blood\ \(0\)\
\-\ cell\\ count\\.\ \(16\)\
\-\ this\\ case\\,\\ as\\ originally\\ seen\\,\\ was\\ more\\ suspicious\\ for\\ metastases\\ given\\ patients\\ history\\ of\\ colon\\ ca\\.\\ however\\,\\ the\\ lesion\\ remained\\ stable\\ over\\ time\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adrenal\\:\\ 0\\.3759650268180368\ \(0\)\
\-\ myelolipoma\\:\\ 0\\.24641638863257312\ \(0\)\
\-\ over\\:\\ 0\\.2257239556091068\ \(0\)\
\-\ stability\\:\\ 0\\.20478282215932772\ \(0\)\
\-\ gland\\:\\ 0\\.1648831957093129\ \(0\)\
\-\ metastases\\:\\ 0\\.16409245032481212\ \(0\)\
\-\ colon\\:\\ 0\\.1545470602530796\ \(0\)\
\-\ lesion\\:\\ 0\\.1459647428042358\ \(0\)\
\-\ given\\:\\ 0\\.13962487834465356\ \(0\)\
\-\ intractable\\:\\ 0\\.1289977969194145\ \(0\)\
\-\ fat\\:\\ 0\\.12626180351166236\ \(0\)\
\-\ attenuated\\:\\ 0\\.12422510188354824\ \(0\)\
\-\ for\\:\\ 0\\.12303918925830869\ \(0\)\
\-\ colectomy\\:\\ 0\\.12224628227645092\ \(0\)\
\-\ ganglioneuroma\\:\\ 0\\.12133372127784559\ \(0\)\
\-\ time\\:\\ 0\\.12030728616027082\ \(0\)\
\-\ 10\\:\\ 0\\.1186883712444929\ \(0\)\
\-\ list\\:\\ 0\\.1124244086226379\ \(0\)\
\-\ post\\:\\ 0\\.11044415205841954\ \(0\)\
\-\ paraganglioma\\:\\ 0\\.11038892960792111\ \(0\)\
\-\ imaging\\:\\ 0\\.10666924313623316\ \(0\)\
\-\ pseudotumor\\:\\ 0\\.10539138432539276\ \(0\)\
\-\ originally\\:\\ 0\\.10333629005074463\ \(0\)\
\-\ remained\\:\\ 0\\.10036422432282523\ \(0\)\
\-\ op\\:\\ 0\\.09538344458790683\ \(0\)\
\-\ characteristics\\:\\ 0\\.09305957583414906\ \(0\)\
\-\ higher\\:\\ 0\\.0921742668790988\ \(0\)\
\-\ suspicious\\:\\ 0\\.09068391362618272\ \(0\)\
\-\ period\\:\\ 0\\.08873019306715443\ \(0\)\
\-\ despite\\:\\ 0\\.0883082514182164\ \(0\)\
\-\ iii\\:\\ 0\\.08762651901068617\ \(0\)\
\-\ ca\\:\\ 0\\.0865873308657404\ \(0\)\
\-\ count\\:\\ 0\\.08379083602604866\ \(0\)\
\-\ total\\:\\ 0\\.08315537422705893\ \(0\)\
\-\ foci\\:\\ 0\\.08294849935011163\ \(0\)\
\-\ measures\\:\\ 0\\.08274400239797897\ \(0\)\
\-\ the\\:\\ 0\\.0810009838270753\ \(0\)\
\-\ adenoma\\:\\ 0\\.08091024113692703\ \(0\)\
\-\ stage\\:\\ 0\\.08081877029812923\ \(0\)\
\-\ stable\\:\\ 0\\.0802796066446975\ \(0\)\
\-\ considered\\:\\ 0\\.07908168048256126\ \(0\)\
\-\ attenuation\\:\\ 0\\.07765127338155357\ \(0\)\
\-\ 14\\:\\ 0\\.07576916634215637\ \(0\)\
\-\ emergency\\:\\ 0\\.07529471051944248\ \(0\)\
\-\ vomiting\\:\\ 0\\.07509518275759258\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.07345371075325692\ \(0\)\
\-\ obstruction\\:\\ 0\\.0710855887187264\ \(0\)\
\-\ status\\:\\ 0\\.07082356573581523\ \(0\)\
\-\ was\\:\\ 0\\.07073814151565808\ \(0\)\
\-\ this\\:\\ 0\\.06974521895075575\ \(0\)\
\-\ benign\\:\\ 0\\.06971441667116236\ \(0\)\
\-\ contributory\\:\\ 0\\.06937552949240659\ \(0\)\
\-\ enlarged\\:\\ 0\\.06918473904245843\ \(0\)\
\-\ elevated\\:\\ 0\\.06918473904245843\ \(0\)\
\-\ followed\\:\\ 0\\.06853263844033357\ \(0\)\
\-\ cancer\\:\\ 0\\.06759722446626032\ \(0\)\
\-\ right\\:\\ 0\\.06729398714642998\ \(0\)\
\-\ white\\:\\ 0\\.06695795669036969\ \(0\)\
\-\ bowel\\:\\ 0\\.06512959074064205\ \(0\)\
\-\ day\\:\\ 0\\.06464519745525817\ \(0\)\
\-\ month\\:\\ 0\\.061735447163921965\ \(0\)\
\-\ region\\:\\ 0\\.06070467284696725\ \(0\)\
\-\ focal\\:\\ 0\\.06070467284696725\ \(0\)\
\-\ likely\\:\\ 0\\.060645859441487704\ \(0\)\
\-\ however\\:\\ 0\\.06006817755650463\ \(0\)\
\-\ of\\:\\ 0\\.0595814114933044\ \(0\)\
\-\ months\\:\\ 0\\.05907338832486664\ \(0\)\
\-\ blood\\:\\ 0\\.05893951983053675\ \(0\)\
\-\ cell\\:\\ 0\\.05805498778240537\ \(0\)\
\-\ patients\\:\\ 0\\.05709174002884446\ \(0\)\
\-\ more\\:\\ 0\\.055726975917062375\ \(0\)\
\-\ is\\:\\ 0\\.0555855676515748\ \(0\)\
\-\ noted\\:\\ 0\\.05380802525806719\ \(0\)\
\-\ other\\:\\ 0\\.05270359971628951\ \(0\)\
\-\ demonstrates\\:\\ 0\\.05098574393080304\ \(0\)\
\-\ case\\:\\ 0\\.05098574393080304\ \(0\)\
\-\ large\\:\\ 0\\.05084980409879417\ \(0\)\
\-\ non\\:\\ 0\\.04815330946377286\ \(0\)\
\-\ seen\\:\\ 0\\.0477790505066565\ \(0\)\
\-\ within\\:\\ 0\\.04674157983362295\ \(0\)\
\-\ by\\:\\ 0\\.043097079129646686\ \(0\)\
\-\ and\\:\\ 0\\.041941910060087004\ \(0\)\
\-\ be\\:\\ 0\\.04116903998672463\ \(0\)\
\-\ as\\:\\ 0\\.040770752756900945\ \(0\)\
\-\ with\\:\\ 0\\.03974467424831612\ \(0\)\
\-\ history\\:\\ 0\\.03877374086842529\ \(0\)\
\-\ mass\\:\\ 0\\.03876515653100638\ \(0\)\
\-\ ct\\:\\ 0\\.03863688604778448\ \(0\)\
\-\ patient\\:\\ 0\\.03300848307227097\ \(0\)\
\-\ on\\:\\ 0\\.030650682964850247\ \(0\)\
\-\ to\\:\\ 0\\.025371440530645856\ \(0\)\
